The supply of non-registered, rare pharmaceuticals or medicines under registered prescriptions occurred due to patients continuously shows interest in pharmaceutical products which none can supply in their local countries, or due to the patients complaints regarding the impossibility to obtain those rare pharmaceuticals on the local markets.

Our strength as a trustable pharmaceutical Wholesaler combined with our very well established partner network across the European Union and outside enabled us as a company to provide a wide range of Orphan drugs dedicated to the single treatment of rare diseases for the patients with special needs.

For further information please visit the homepage of The European Medicines Agency (EMA).